Sheau Wen Lok - Search Results

Year	Number of Results
2012	1
2014	1
2015	1
2018	2
2020	1
2021	2
2022	5
2023	2
2024	0

1

Real-World Outcomes of Ribociclib and Aromatase Inhibitor Use in First Line Hormone Receptor Positive, HER2-Negative Metastatic Breast Cancer.

Wong V, de Boer R, Baron-Hay S, Blum R, Boyle F, Chua S, Clarke K, Cuff K, Green M, Lim E, Mok K, Nott L, Nottage M, Tafreshi A, Tsoi D, Uccellini A, Hong W, Gibbs P, Lok SW. Wong V, et al. Among authors: lok sw. Clin Breast Cancer. 2022 Dec;22(8):792-800. doi: 10.1016/j.clbc.2022.08.011. Epub 2022 Aug 30. Clin Breast Cancer. 2022. PMID: 36151018

2

Mismatch repair deficiency assessment by immunohistochemistry: for Lynch syndrome screening and beyond.

Wong HL, Christie M, Gately L, Tie J, Lee B, Semira C, Lok SW, Wong R, Gibbs P. Wong HL, et al. Among authors: lok sw. Future Oncol. 2018 Nov;14(26):2725-2739. doi: 10.2217/fon-2018-0319. Epub 2018 Jul 13. Future Oncol. 2018. PMID: 30004261 Review.

3

Leveraging Comprehensive Cancer Registry Data to Enable a Broad Range of Research, Audit and Patient Support Activities.

Lee B, Gately L, Lok SW, Tran B, Lee M, Wong R, Markman B, Dunn K, Wong V, Loft M, Jalili A, Anton A, To R, Andrews M, Gibbs P. Lee B, et al. Among authors: lok sw. Cancers (Basel). 2022 Aug 26;14(17):4131. doi: 10.3390/cancers14174131. Cancers (Basel). 2022. PMID: 36077668 Free PMC article. Review.

4

Real-World Outcomes in Patients With Brain Metastases Secondary to HER2-Positive Breast Cancer: An Australian Multi-centre Registry-based Study.

Tung I, Moldovan C, Wong V, De Boer R, Yeo B, Malik L, Greenberg S, Anton A, Nott L, Barnett F, Collins IM, Lombard J, Nottage M, Sahu A, Torres J, Gibbs P, Lok SW. Tung I, et al. Among authors: lok sw. Clin Breast Cancer. 2022 Oct;22(7):e764-e772. doi: 10.1016/j.clbc.2022.07.005. Epub 2022 Jul 14. Clin Breast Cancer. 2022. PMID: 35941066

5

Stage dependent recurrence patterns and post-recurrence outcomes in non-metastatic colon cancer.

Gately L, Jalali A, Semira C, Faragher I, Croxford M, Ananda S, Kosmider S, Field K, Lok SW, Gard G, Steel M, Lee M, Wong R, Wong HL, Gibbs P. Gately L, et al. Among authors: lok sw. Acta Oncol. 2021 Sep;60(9):1106-1113. doi: 10.1080/0284186X.2021.1943519. Epub 2021 Jun 29. Acta Oncol. 2021. PMID: 34184594

6

Pertuzumab study in the neoadjuvant setting for HER2-positive nonmetastatic breast cancer in Australia (PeRSIA).

Lok SW, De Boer R, Baron-Hay S, Button P, Devitt B, Forster BC, Fox P, Harold M, Ketheeswaran S, Kichenadasse G, Kiely BE, Marx G, Nott L, Pellegrini L, Tafreshi A, Gibbs P. Lok SW, et al. Int J Cancer. 2023 Jan 15;152(2):267-275. doi: 10.1002/ijc.34245. Epub 2022 Aug 25. Int J Cancer. 2023. PMID: 36005450 Free article.

7

Uptake of bone-modifying agents in patients with HER2+ metastatic breast cancer with bone metastases - prospective data from a multi-site Australian registry.

Wong V, de Boer R, Dunn C, Anton A, Malik L, Greenberg S, Yeo B, Nott L, Collins IM, Torres J, Barnett F, Nottage M, Gibbs P, Lok SW. Wong V, et al. Among authors: lok sw. Intern Med J. 2022 Oct;52(10):1707-1716. doi: 10.1111/imj.15376. Epub 2022 May 24. Intern Med J. 2022. PMID: 34002929

8

Cancer clinical trial vs real-world outcomes for standard of care first-line treatment in the advanced disease setting.

Kostos L, Hong W, Lee B, Tran B, Lok SW, Anton A, Gard G, To YH, Wong V, Shapiro J, Wong R, Wong S, de Boer R, Gibbs P. Kostos L, et al. Among authors: lok sw. Int J Cancer. 2021 Jul 15;149(2):409-419. doi: 10.1002/ijc.33568. Epub 2021 Apr 13. Int J Cancer. 2021. PMID: 33729581 Free article.

9

Addition of endocrine therapy to dual anti-HER2 targeted therapy in initial treatment of HER2 + /HR + metastatic breast cancer.

Loft M, Lok SW, De Boer R, Malik L, Greenberg S, Yeo B, Anton A, Nottage M, Wong V, Nott L, Collins IM, Torres J, Barnett F, Lombard JM, Gibbs P, Gately L. Loft M, et al. Among authors: lok sw. Breast Cancer Res Treat. 2023 Feb;198(1):67-74. doi: 10.1007/s10549-022-06856-1. Epub 2023 Jan 9. Breast Cancer Res Treat. 2023. PMID: 36624321

10

Translation of clinical trial outcomes to metastatic colorectal cancer patients in community practice.

Lok SW, Wong HL, Kosmider S, Field K, Tie J, Desai J, Bae S, Tacey M, Skinner I, Jones I, Gibbs P. Lok SW, et al. Asia Pac J Clin Oncol. 2014 Dec;10(4):361-7. doi: 10.1111/ajco.12260. Epub 2014 Aug 17. Asia Pac J Clin Oncol. 2014. PMID: 25131961

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

14 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Results by year